Francis Tapon

Names

Identifer

Contact

Affiliations

• University of Guelph / Gordon Lang School of Business and Economics / Department of Economics and Finance (weight: 50%)
  • EDIRC entry
  • location:
• Duke University / Fuqua School of Business / Economics Area (weight: 50%)
  • EDIRC entry
  • location:

Research profile

author of:

• Are You Paying Your Employees to Cheat? An Experimental Investigation (RePEc:bpj:bejeap:v:10:y:2010:i:1:n:35)
  by Cadsby C. Bram & Song Fei & Tapon Francis
• Ridge Regression Estimates of the Profitability-Concentration Hypothesis: Some Canadian Evidence Revisited [Profitability and Market Structure: A Cross-Section Comparison of Canadian and American Manu (RePEc:cje:issued:v:15:y:1982:i:3:p:541-49)
  by David Prescott & Francis Tapon
• Compulsory Licensing as a Policy Instrument (RePEc:cpp:issued:v:10:y:1984:i:1:p:74-77)
  by James J. McRae & Francis Tapon
• Profit risk, market power and pricing decisions of large firms (RePEc:eee:ecolet:v:6:y:1980:i:1:p:67-73)
  by Christofides, Louis N. & Tapon, Francis
• Testing weak form efficiency on the Toronto Stock Exchange (RePEc:eee:empfin:v:18:y:2011:i:4:p:661-691)
  by Alexeev, Vitali & Tapon, Francis
• Predictive blends: Fundamental Indexing meets Markowitz (RePEc:eee:jbfina:v:100:y:2019:i:c:p:28-42)
  by Pysarenko, Sergiy & Alexeev, Vitali & Tapon, Francis
• A transaction costs analysis of innovations in the organization of pharmaceutical R & D (RePEc:eee:jeborg:v:12:y:1989:i:2:p:197-213)
  by Tapon, Francis
• The optimal organization of research: evidence from eight case studies of pharmaceutical firms (RePEc:eee:jeborg:v:31:y:1996:i:3:p:381-399)
  by Tapon, Francis & Cadsby, Charles Bram
• Some empirical evidence on post-patent barriers to entry in the Canadian pharmaceutical industry (RePEc:eee:jhecon:v:4:y:1985:i:1:p:43-61)
  by McRae, James J. & Tapon, Francis
• The Impact of Risk-Aversion and Stress on the Incentive Effect of Performance-Pay (RePEc:eme:rexezz:s0193-230620160000019007)
  by C. Bram Cadsby & Fei Song & Francis Tapon
• Um estudo da difusão do emprego de energia nuclear nos serviços industriais de utilidade pública de eletricidade nos EUA (RePEc:fgv:epgrbe:v:34:y:1980:i:1:a:242)
  by Lago, Luiz A. Corrêa do & Tapon, Francis
• Unknown item RePEc:fth:guelph:1992-15 (paper)
• Green as Strategy: Lessons from the Chemical Industry (RePEc:gue:guelph:1991-17)
  by Tapon, F. & Leighton, T.
• The Creation of Competitive Advantage Through Research in the Pharmaceutical Industry: A Transaction Costs Analysis (RePEc:gue:guelph:1993-8)
  by Tapon, F. & Cadsby, C.B.
• Life after Bill C-91: Is There a Future for Canadian Generic Drug Manufacturers? (RePEc:gue:guelph:1993-9)
  by Tapon, F. & Saraburam, M.M.A.
• Outsourcing of Research by Pharmaceutical and Biotechnology Firms (RePEc:gue:guelph:1997-2)
  by Tapon, F. & Thong, M.
• Stock Return Volatility and the Current Internet Phenomenon (RePEc:gue:guelph:2003-3)
  by Tapon, F. & Sun, Y. & Liu, Y.
• Are You Paying Your Employees to Cheat? An Experimental Investigation (RePEc:gue:guelph:2008-10)
  by C. Bram Cadsby & Fei Song & Francis Tapon
• The Impact of Risk Aversion and Stress on the Incentive Effect of Performance Pay (RePEc:gue:guelph:2009-12)
  by C. Bram Cadsby & Fei Song & Francis Tapon
• Testing Weak Form Efficiency on the Toronto Stock Exchange (RePEc:gue:guelph:2010-02.)
  by Vitali Alexeev & Francis Tapon
• The Capital Asset Pricing Model: An Evaluation of its Potential as a Strategic Planning Tool (RePEc:inm:ormnsc:v:28:y:1982:i:10:p:1166-1173)
  by Thomas H. Naylor & Francis Tapon
• Erratum To "The Capital Asset Pricing Model: An Evaluation of Its Potential as a Strategic Planning Tool" By Thomas H. Naylor and Francis Tapon (RePEc:inm:ormnsc:v:29:y:1983:i:5:p:633-633)
  by Bruce James Brownlee
• Note--The Capital Asset Pricing Model and Strategic Planning: Response to Wernerfelt (RePEc:inm:ormnsc:v:31:y:1985:i:4:p:510-511)
  by T. H. Naylor & F. Tapon
• Discretionary Expenditures and Profit Risk Management: The Galbraith-Caves Hypothesis (RePEc:oup:qjecon:v:93:y:1979:i:2:p:303-319.)
  by Louis N. Christofides & Francis Tapon
• Uncertainty, Market Structure and Performance: The Galbraith-Caves Hypothesis Revisited (RePEc:oup:qjecon:v:93:y:1979:i:4:p:719-726.)
  by Louis N. Christofides & Francis Tapon
• Unknown item RePEc:taf:apfelt:v:2:y:2006:i:2:p:105-109 (article)
• Unknown item RePEc:taf:apfiec:v:16:y:2006:i:16:p:1171-1183 (article)
• Equity Portfolio Diversification: How Many Stocks are Enough? Evidence from Five Developed Markets (RePEc:tas:wpaper:17313)
  by Alexeev, Vitali & Tapon, Francis
• What Australian investors need to know to diversity their portfolios (RePEc:tas:wpaper:17314)
  by Alexeev, Vitali & Tapon, Francis
• How many stocks are enough for diversifying Canadian institutional portfolios? (RePEc:tas:wpaper:17836)
  by Alexeev, Vitali & Tapon, Francis
• A New Test of the Administered Pricing Hypothesis with Canadian Data (RePEc:ucp:jnlbus:v:52:y:1979:i:3:p:409-27)
  by McRae, James J & Tapon, Francis
• Diversification, Canadian Style: How many stocks are enough for diversifying Canadian institutional portfolios? (RePEc:uts:ppaper:2014-3)
  by Vitali Alexeev & Francis Tapon
• The number of stocks in your portfolio should be larger than you think: diversification evidence from five developed markets (RePEc:uts:ppaper:2014-4)
  by Vitali Alexeev & Francis Tapon